Targeting autophagy increases the efficacy of proteasome inhibitor treatment in multiple myeloma by induction of apoptosis and activation of JNK

BACKGROUND: The therapeutic armamentarium in multiple myeloma has been significantly broadened by proteasome inhibitors, highly efficient means in controlling of multiple myeloma. Despite the developments of therapeutic regimen in treatment of multiple myeloma, still the complete remission requires...

Descripción completa

Detalles Bibliográficos
Autores principales: Salimi, Azam, Schroeder, Kema Marlen, Schemionek-Reinders, Mirle, Vieri, Margherita, Maletzke, Saskia, Gezer, Deniz, Masouleh, Behzad Kharabi, Appelmann, Iris
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9258169/
https://www.ncbi.nlm.nih.gov/pubmed/35790913
http://dx.doi.org/10.1186/s12885-022-09775-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9258169/
https://www.ncbi.nlm.nih.gov/pubmed/35790913
http://dx.doi.org/10.1186/s12885-022-09775-y

Ejemplares similares